CXI Healthcare Technology Group (XKRX:900120) Debt-to-Equity : 0.00 (As of Sep. 2024)

View and export this data going back to 2010. Start your Free Trial

What is CXI Healthcare Technology Group Debt-to-Equity?

CXI Healthcare Technology Group's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩30 Mil. CXI Healthcare Technology Group's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Sep. 2024 was ₩262 Mil. CXI Healthcare Technology Group's Total Stockholders Equity for the quarter that ended in Sep. 2024 was ₩483,047 Mil. CXI Healthcare Technology Group's debt to equity for the quarter that ended in Sep. 2024 was 0.00.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for CXI Healthcare Technology Group's Debt-to-Equity or its related term are showing as below:

During the past 13 years, the highest Debt-to-Equity Ratio of CXI Healthcare Technology Group was 0.08. The lowest was 0.00. And the median was 0.00.

XKRX:900120's Debt-to-Equity is not ranked ^*
in the Drug Manufacturers industry.
Industry Median: 0.27
* Ranked among companies with meaningful Debt-to-Equity only.

CXI Healthcare Technology Group Debt-to-Equity Historical Data

The historical data trend for CXI Healthcare Technology Group's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

CXI Healthcare Technology Group Debt-to-Equity Chart

CXI Healthcare Technology Group Annual Data

Trend

Jun15

Jun16

Jun17

Jun18

Jun19

Jun20

Jun21

Jun22

Jun23

Jun24

Debt-to-Equity

Get a 7-Day Free Trial

0.01

CXI Healthcare Technology Group Quarterly Data
	Dec19	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24
Debt-to-Equity	Get a 7-Day Free Trial															-	-	-	-	-

Competitive Comparison of CXI Healthcare Technology Group's Debt-to-Equity

For the Drug Manufacturers - Specialty & Generic subindustry, CXI Healthcare Technology Group's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

CXI Healthcare Technology Group's Debt-to-Equity Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, CXI Healthcare Technology Group's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where CXI Healthcare Technology Group's Debt-to-Equity falls into.

CXI Healthcare Technology Group Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

CXI Healthcare Technology Group's Debt to Equity Ratio for the fiscal year that ended in Jun. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(30.213	+	157.279)	/	481136.634
	=	0.00

CXI Healthcare Technology Group's Debt to Equity Ratio for the quarter that ended in Sep. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(30.23	+	261.909)	/	483047.168
	=	0.00

CXI Healthcare Technology Group (XKRX:900120) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

CXI Healthcare Technology Group Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of CXI Healthcare Technology Group's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

CXI Healthcare Technology Group Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » CXI Healthcare Technology Group Ltd (XKRX:900120) » Definitions » Debt-to-Equity

Traded in Other Exchanges

N/A

Address

Century Yard, Cricket Square, PO Box 902, 3rd Floor, Grand Cayman, CYM, KY1-1103

Website

http://www.ckhfnh.co.kr

CXI Healthcare Technology Group Ltd is a food manufacturing and distribution company. It operates through subsidiaries that manufacture nutritional supplements. The company's products include Traditional Chinese medicines in the form of a capsule, drinks, and tea. All of its products are marketed only in China.

CXI Healthcare Technology Group Headlines

No Headlines